Pure Global

“Dimension” Everolimus (EVRO) Assay - Taiwan Registration 4c34672ed4d3839e60e0c551d3733a95

Access comprehensive regulatory information for “Dimension” Everolimus (EVRO) Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 4c34672ed4d3839e60e0c551d3733a95 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
4c34672ed4d3839e60e0c551d3733a95
Registration Details
Taiwan FDA Registration: 4c34672ed4d3839e60e0c551d3733a95
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Dimension” Everolimus (EVRO) Assay
TW: “德曼遜” 癌伏妥試劑檢驗組
Risk Class 2
MD

Registration Details

4c34672ed4d3839e60e0c551d3733a95

Ministry of Health Medical Device Import No. 035243

DHA05603524309

Company Information

United States

Product Details

This product needs to be used with the Dimension clinical chemistry system to quantitatively detect the content of Everolimus in human whole blood.

A Clinical chemistry and clinical toxicology

A3840 SIROLIMUS drug testing system

Imported from abroad; GMP

Dates and Status

May 04, 2022

May 04, 2027